Amid the ongoing race among global companies and institutions for developing a vaccine for the Covid-19, the researchers at the University of Cambridge in the United Kingdom are working on a vaccine prototype that can defeat all kind of Coronaviruses, including the SARS-CoV-2 that causes the Covid-19, reports Economic Times.
According to the report, the Covid-19 causing SARS-CoV-2 is not the only coronavirus that infects humans. Seven types of coronaviruses have been known to infect and cause diseases in humans including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).
Scientists from the University of Cambridge are working to develop a vaccine that fights not just the current one but all coronaviruses in the future.
The clinical trials for the Cambridge University's novel vaccine will reportedly be starting from today (28 August).
The researchers have developed the vaccine named 'DIOS-CoVax2' using the genetic sequencing obtained from Coronaviruses, which are mostly known to spread from bats to humans.
For developing the vaccine, the scientist used 3D computer modelling to tap any mutations and variations which can cause damage and infect the society in the future.
The vaccine project is being funded by the United Kingdom government which is providing a funding of around 1.9 million pound for the research.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!